Medikaloka Hermina PT (JK:HEAL) — Market Cap & Net Worth
Market Cap & Net Worth: Medikaloka Hermina PT (HEAL)
Medikaloka Hermina PT (JK:HEAL) has a market capitalization of $751.82 Million (Rp12.83 Trillion) as of June 17, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #10401 globally and #104 in its home market, demonstrating a 4.38% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medikaloka Hermina PT's stock price Rp835.00 by its total outstanding shares 15365950000 (15.37 Billion). Review debt load of Medikaloka Hermina PT to assess the company's total debt and financial obligations.
Medikaloka Hermina PT Market Cap History: 2018 to 2026
Medikaloka Hermina PT's market capitalization history from 2018 to 2026. Data shows change from $448.03 Million to $751.82 Million (-58.23% CAGR).
Index Memberships
Medikaloka Hermina PT is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Jakarta Stock Exchange Composite Index
JKSE
|
$485.06 Billion | 0.15% | #102 of 864 |
Weight: Medikaloka Hermina PT's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Medikaloka Hermina PT Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medikaloka Hermina PT's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Medikaloka Hermina PT's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.00x
Medikaloka Hermina PT's market cap is 0.00 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $448.03 Million | $3.06 Trillion | $124.37 Billion | 0.00x | 0.00x |
| 2019 | $628.51 Million | $3.63 Trillion | $343.92 Billion | 0.00x | 0.00x |
| 2020 | $622.08 Million | $4.42 Trillion | $645.64 Billion | 0.00x | 0.00x |
| 2021 | $948.07 Million | $5.82 Trillion | $995.97 Billion | 0.00x | 0.00x |
| 2022 | $1.38 Billion | $4.90 Trillion | $298.60 Billion | 0.00x | 0.00x |
| 2023 | $1.33 Billion | $5.78 Trillion | $437.35 Billion | 0.00x | 0.00x |
| 2024 | $1.47 Billion | $6.74 Trillion | $535.94 Billion | 0.00x | 0.00x |
Competitor Companies of HEAL by Market Capitalization
Companies near Medikaloka Hermina PT in the global market cap rankings as of June 17, 2026.
Key companies related to Medikaloka Hermina PT by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #327 globally with a market cap of $80.16 Billion USD.
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1003 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #1050 globally with a market cap of $25.53 Billion USD ( €21.84 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1333 globally with a market cap of $19.50 Billion USD ( RM77.67 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #327 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $396.93 |
| #1003 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1050 | Fresenius SE & Co. KGaA | XETRA:FRE | $25.53 Billion | €38.77 |
| #1333 | IHH Healthcare Bhd | KLSE:5225 | $19.50 Billion | RM8.79 |
Medikaloka Hermina PT Historical Marketcap From 2018 to 2026
Between 2018 and today, Medikaloka Hermina PT's market cap moved from $448.03 Million to $ 751.82 Million, with a yearly change of -58.23%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp751.82 Million | -39.27% |
| 2025 | Rp1.24 Billion | -15.64% |
| 2024 | Rp1.47 Billion | +10.10% |
| 2023 | Rp1.33 Billion | -3.37% |
| 2022 | Rp1.38 Billion | +45.49% |
| 2021 | Rp948.07 Million | +52.40% |
| 2020 | Rp622.08 Million | -1.02% |
| 2019 | Rp628.51 Million | +40.28% |
| 2018 | Rp448.03 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Medikaloka Hermina PT was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $751.82 Million USD |
| MoneyControl | $751.82 Million USD |
| MarketWatch | $751.82 Million USD |
| marketcap.company | $751.82 Million USD |
| Reuters | $751.82 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medikaloka Hermina PT
PT Medikaloka Hermina Tbk, together with its subsidiaries, operates a network of hospitals in Indonesia. The company offers services in the areas of medical acupuncture, pediatrics, surgery, orthopedic surgery, plastic and reconstructive surgery, emergency medicine, forensic and medicolegal, dentistry, clinical nutrition, integrative medicine, cardiology, obstetrics and gynecology, nuclear medici… Read more